North America Hyaluronic Acid Market
市场规模（十亿美元）
CAGR :
% 
 Forecast Period |
2023 –2030 |
 Market Size (Base Year) |
USD 3,986.54 Million |
 Market Size (Forecast Year) |
USD 7,960.24 Million |
 CAGR |
% |
| Major Markets Players |
>北美透明质酸市场，按等级（化妆品级和药品级）、类型（水解透明质酸、乙酰化透明质酸钠和透明质酸钠）、应用（美学、骨关节炎、药物 API、化妆品、眼科和其他）、最终用户（医疗水疗和美容中心、皮肤病诊所和整容手术中心）、分销渠道（直接招标和零售销售）行业趋势和预测到 2030 年。
北美透明质酸市场分析与洞察
透明质酸主要用于美容和护肤产品。它可快速恢复伤口，减少面部细纹、皱纹和皮肤老化，并治愈割伤和烧伤等。它含有维生素 C，可提亮肤色。含有透明质酸的美容产品（例如保湿霜、面霜、爽肤水和精华液）可为皮肤提供营养。
Data Bridge Market Research 分析称，在 2023 年至 2030 年的预测期内，该市场将以 9.0% 的复合年增长率增长，预计到 2030 年将从 2022 年的 39.8654 亿美元达到 79.6024 亿美元。
|
报告指标 |
细节 |
|
预测期 |
2023 至 2030 年 |
|
基准年 |
2022 |
|
历史岁月 |
2021 (可定制为 2020-2016) |
|
定量单位 |
收入（百万美元） |
|
涵盖的领域 |
按等级（化妆品级和药品级）、类型（水解透明质酸、乙酰化透明质酸钠和透明质酸钠）、应用（美学、骨关节炎、药品 API、化妆品、眼科等）、最终用户（医疗水疗和美容中心、皮肤病诊所和整形外科中心）、分销渠道（直接招标和零售）。 |
|
覆盖国家 |
美国、加拿大和墨西哥。 |
|
涵盖的市场参与者 |
Fidia Farmaceutici SpA、AbbVie.、华熙生物科技股份有限公司、GALDERMA、LG Chem、Anika Therapeutics, Inc.、Abbott、VIRCHOW BIOTECH、Kewpie Corporation、Merz North America, Inc.、LABORATOIRES FILLMED、Prollenium Medical Technologies.、Huons、Contipro as、Lifecore Biomedical, Inc.、BioScience GmbH、Teoxane、Bioxis Pharmaceuticals、山东拓普生物科技有限公司、Bohus BioTech AB、RIVER PHARMA srl、Symatese、Oceania International LLC 旗下的 Stanford Chemicals、Bioiberica SAU、GENESIS pharmacy services 和 Brickell Men's Products 等 |
市场定义
透明质酸 (HA) 也被称为透明质酸，是一种阴离子、非硫酸化的氨基葡聚糖，广泛分布于结缔、上皮和神经组织中。透明质酸是关节软骨的重要组成部分，像一层外衣（软骨细胞）一样包裹着软骨中的每个细胞。软骨的坚固性是由于这些聚集体吸收了水（其抗压性）。软骨中透明质酸的分子量（大小）会随着年龄的增长而减小，但数量会增加。人体自然含有 HA。关节和眼睛中含有最多的 HA。这种化学物质能够保持皮肤的光滑、湿润。因此，许多整形外科医生将其用作注射剂来延缓皮肤衰老的迹象。
微创手术的日益普及以及全球对医药和化妆品中透明质酸的认识和需求不断增长是预测期内市场增长的主要驱动因素。研究质量的大幅提高以及研究机会的增加得益于市场参与者采取的各种战略举措。多年来，他们采取了产品发布、合作、合并、收购等举措，预计将引领并创造更多市场机会。
北美透明质酸市场动态
本节旨在了解市场驱动因素、优势、机遇、限制和挑战。下面将详细讨论所有这些内容：
司机
- 提高对美容注射剂或真皮填充剂的认识
基于透明质酸的真皮填充剂是一种侵入性较小的美容方法。皮肤病问题在全球很常见。了解治疗皮肤相关问题和恢复皮肤皱纹的产品已成为主要关注点。已经启动了各种计划来提高人们对正确使用透明质酸注射剂的认识。
意识的增强将使消费者能够选择正确的痤疮和皱纹治疗方法，并根据正确的原因选择正确的产品（肉毒杆菌注射、真皮填充剂）。这将导致销售额上升、产品组合增加和产品线扩大。这一因素有望推动市场增长。
- 使用侵入性透明质酸类皮肤填充剂
基于透明质酸的真皮填充剂是一种侵入性较小的美容方法，在全球范围内正迅速增加。这些是用于面部修复、面部体积恢复和美学改善的流行美容程序。
它们用途广泛，可用于治疗细纹和皱纹。此外，它们还用于治疗痤疮、皱纹和疤痕以及丰唇、丰颊和丰下巴。老年人口的增加提高了非侵入性手术方案的必要性。
使用透明质酸基真皮填充剂将减少选择常规手术的机会。治疗成本最低，这一因素将促进市场增长。
限制
- 未经授权或替代性皮肤填充剂的供应阻碍了市场
随着透明质酸类真皮填充剂的美容应用的广泛普及，预计这些产品的若干限制因素将在未来几年阻碍北美市场的增长。
由于其高有效率、患者满意度以及在动态皱纹方面的使用率，肉毒杆菌毒素类填充剂正在全球引领非手术美容手术。
此外，其他可生物降解的填充剂，如羟基磷灰石钙 (CaHA) 和聚-L-乳酸，作为高寿命植入物的替代填充剂越来越受欢迎。
据观察，医生们不愿意使用低成本的非法产品，因为这样做存在风险。相反，真皮填充剂领域存在的非法产品将加剧价格竞争，尤其是在透明质酸领域。提供高单价的大型公司有能力通过提供多种产品组合并在不同产品部门销售产品来竞争。
为了弥补透明质酸真皮填充剂价格较低的缺陷，颗粒和聚合物制造商必须大力推广产品。该细分市场的产品各不相同。制造商将更多地关注真皮填充剂所用材料的强度，而不是成本价格。
机会
- 透明质酸产品的新技术和发展
先进的创新技术改善了皮肤和其他身体部位的美容治疗，护肤品行业是变化最快的行业之一。本土品牌的活性成分、成分型护肤品和美容领域正在见证投资的增加，消费者也积极参与其中。先进的创新技术和透明质酸产品的发展推动了市场对透明质酸的需求。
透明质酸真皮产品以透明质酸为基础，可矫正面部瑕疵、补充体积并突出面部某些部位。真皮产品的进步为增强、恢复和定义面部特征提供了一种有效的方法。透明质酸基产品和真皮填充剂程序的进步吸引了消费者对化妆品的兴趣。因此，这意味着透明质酸真皮产品的技术进步有望成为市场增长的机会。
挑战
- 产品召回不断升级
透明质酸类产品的召回极大地影响了市场增长。监管机构因健康和安全问题召回美容和化妆品。每个国家都有自己的监管机构，负责监督与医疗保健相关的产品的监管。
出于对患者健康安全问题的考虑，例如内容不准确或成分错误，公司或监管机构召回产品是影响市场增长的一些主要问题，因为患者的安全和健康是任何市场在市场上推出产品的最重要标准。
最新动态
- 2022年2月，艾尔建（AbbVie Inc. 的子公司）宣布 FDA 批准 JUVÉDERM VOLBELLA XC 用于改善21岁以上成年人的眶下凹陷。此举有助于该公司扩大其在美国市场的美容产品组合。
- 2021年2月，总部位于捷克共和国的知名透明质酸制造商Contipro宣布推出其名为HyRetin的新型抗衰老和抗痤疮治疗产品，该产品可提高皮肤的可见度。
北美透明质酸市场范围
北美透明质酸市场根据等级、类型、应用、最终用户和分销渠道分为五个显著的细分市场。这些细分市场之间的增长将帮助您分析行业中增长微弱的细分市场，并为用户提供有价值的市场概览和市场洞察，以便做出战略决策，确定核心市场应用。
年级
- 化妆品级
- 医药级
根据等级，市场分为化妆品级和药品级。
类型
- 水解透明质酸
- 乙酰化透明质酸钠
- 透明质酸钠
根据类型，市场分为水解透明质酸、乙酰化透明质酸钠和透明质酸钠。
应用
- 美学
- 骨关节炎
- 制药原料药
- 化妆品
- 眼科
- 其他的
根据应用，市场细分为美学、骨关节炎、药物 API、化妆品、眼科等。
最终用户
- 制药行业
- 皮肤科诊所
- 整形外科中心
- 其他的
根据最终用户，市场分为制药行业、皮肤病诊所、整形外科中心和其他行业。
分销渠道
- 直接招标
- 零售销售
根据分销渠道，市场分为直接招标和零售。
北美透明质酸市场区域分析/见解
对北美透明质酸市场进行了分析，并按国家、等级、类型、应用、最终用户和分销渠道提供了市场规模洞察和趋势。
本市场报告涵盖的国家包括美国、加拿大和墨西哥。
- 2023 年，美国在市场份额和收入方面将主导北美透明质酸市场，并将在预测期内继续保持主导地位。这是由于该地区对美容注射剂或真皮填充剂的认识不断提高。
报告的国家部分还提供了影响单个市场因素和市场法规变化的信息，这些因素和变化会影响市场的当前和未来趋势。新旧销售、国家人口统计、疾病流行病学和进出口关税等数据点是预测单个国家市场情况的一些主要指标。此外，在对国家数据进行预测分析时，还考虑了北美品牌的存在和可用性以及它们因本土和国内品牌的竞争而面临的挑战以及销售渠道的影响。
竞争格局和北美透明质酸市场份额分析
北美透明质酸市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、北美业务、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度以及应用主导地位。以上提供的数据点仅与公司对市场的关注有关。
北美透明质酸市场的一些主要参与者包括 Fidia Farmaceutici SpA、AbbVie.、Bloomage Biotechnology Co., Ltd.、GALDERMA、LG Chem、Anika Therapeutics, Inc.、Abbott、VIRCHOW BIOTECH、Kewpie Corporation、Merz North America, Inc.、LABORATOIRES FILLMED、Prollenium Medical Technologies.、Huons、Contipro as、Lifecore Biomedical, Inc.、BioScience GmbH、Teoxane、Bioxis Pharmaceuticals、SHANDONG TOPSCIENCE BIOTECH CO., LTD.、Bohus BioTech AB、RIVER PHARMA srl、Symatese、Stanford Chemicals owned by Oceania International LLC、Bioiberica SAU、GENESIS pharmacy services 和 Brickell Men's Products 等。
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
目录
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF THE NORTH AMERICA HYALURONIC ACID MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATIONS
1.6 MARKETS COVERED
2 NORTH AMERICA HYALURONIC ACID MARKET: SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 DBMR TRIPOD DATA VALIDATION MODEL
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.6 MULTIVARIATE MODELLING
2.7 GRADE SEGMENT LIFELINE CURVE
2.8 DBMR MARKET POSITION GRID
2.9 VENDOR SHARE ANALYSIS
2.1 MARKET END USER COVERAGE GRID
2.11 SECONDARY SOURCES
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTEL ANALYSIS
4.2 PORTER'S FIVE FORCES
4.3 NUMBER OF AESTHETIC SURGERY PROCEDURES
4.4 INDUSTRY INSIGHTS
5 REGULATORY FRAMEWORK
5.1 EGULATORY SCENARIO IN THE U.S.
5.2 REGULATORY SCENARIO IN EUROPE
5.3 REGULATORY SCENARIO IN CHINA
5.4 REGULATORY SCENARIO IN AUSTRALIA
6 MARKET OVERVIEW
6.1 DRIVERS
6.1.1 INCREASING AWARENESS TOWARDS COSMETIC INJECTABLES OR DERMAL FILLERS
6.1.2 USE OF INVASIVE HYALURONIC ACID BASED DERMAL FILLERS
6.1.3 RISE IN PRODUCT APPROVALS
6.1.4 GROWING POPULARITY OF NON-SURGICAL OR MINIMALLY INVASIVE COSMETIC PROCEDURES
6.2 RESTRAINTS
6.2.1 AVAILABILITY OF UNAUTHORIZED OR ALTERNATIVE DERMAL FILLERS TO HAMPER MARKET
6.2.2 POOR MEDICAL REIMBURSEMENT POLICIES
6.2.3 SIDE EFFECTS RELATED TO HYALURONIC ACID INJECTION
6.3 OPPORTUNITIES
6.3.1 NEW TECHNOLOGY AND DEVELOPMENTS IN HYALURONIC ACID PRODUCTS
6.3.2 NUTRICOSMETICS HYALURONIC ACID DERMAL FILLERS
6.3.3 STRATEGIC INITIATIVES BY MARKET PLAYERS
6.3.4 INCREASING RESEARCH AND DEVELOPMENT
6.4 CHALLENGES
6.4.1 ESCALATING PRODUCT RECALL
6.4.2 LACK OF EXPERTISE
7 NORTH AMERICA HYALURONIC ACID MARKET, BY GRADE
7.1 OVERVIEW
7.2 COSMETIC GRADE
7.2.1 GENDER
7.2.1.1 FEMALE PRODUCTS
7.2.1.2 MEN’S PRODUCT
7.2.2 PRODUCT TYPE
7.2.2.1 SKIN CARE
7.2.2.2 MAKEUP
7.2.2.3 CLEANSING
7.2.2.4 HAIR CARE
7.2.2.5 OTHERS
7.2.3 PROCEDURE
7.2.3.1 WRINKLE REMOVAL
7.2.3.2 SKIN SMOOTHENING
7.2.3.3 FACE LIFT
7.2.3.4 LIP AUGMENTATION
7.2.3.5 CHIN AUGMENTATION
7.2.3.6 FAT INJECTION
7.2.3.7 FACE LINE CORRECTION
7.2.3.8 ACNE SCAR TREATMENT
7.2.3.9 LIP PLUM
7.2.3.10 EAR LOBE REJUVENATION
7.2.3.11 LIPOATROPHY TREATMENT
7.2.3.12 OTHERS
7.3 PHARMACEUTICAL GRADE
7.3.1 TYPE
7.3.1.1 MEDICAL GRADE HYALURONIC ACID
7.3.1.2 INJECTION GRADE HYALURONIC ACID
7.3.2 PRODUCT TYPE
7.3.2.1 TOPICAL PREPARATIONS
7.3.2.2 INTRA-ARTICULAR INJECTION
7.3.2.2.1 PREFILLED INJECTIONS
7.3.2.2.2 VIAL
7.3.2.3 EYE DROPS
7.3.2.4 ORAL PHARMACEUTICAL PREPARATIONS
7.3.2.5 OTHERS
8 NORTH AMERICA HYALURONIC ACID MARKET, BY TYPE
8.1 OVERVIEW
8.2 SODIUM HYALURONATE
8.2.1 MOLECULAR WEIGHT
8.2.1.1 HIGH MOLECULAR WEIGHT
8.2.1.2 LOW MOLECULAR WEIGHT
8.2.1.3 MEDIUM MOLECULAR WEIGHT
8.2.2 BY TYPE
8.2.2.1 COSMETIC GRADE
8.2.2.1.1 GENDER
8.2.2.1.1.1 FEMALE PRODUCTS
8.2.2.1.1.2 MEN'S PRODUCT
8.2.2.1.2 PRODUCT TYPE
8.2.2.1.2.1 SKIN CARE
8.2.2.1.2.2 MAKEUP
8.2.2.1.2.3 CLEANSING
8.2.2.1.2.4 HAIR CARE
8.2.2.1.2.5 OTHERS
8.2.2.2 PHARMACEUTICAL GRADE
8.2.2.2.1 TYPE
8.2.2.2.1.1 MEDICAL GRADE HYALURONIC ACID
8.2.2.2.1.2 INJECTION GRADE HYALURONIC ACID
8.2.2.2.2 PRODUCT TYPE
8.2.2.2.2.1 TOPICAL PREPARATIONS
8.2.2.2.2.2 INTRA-ARTICULAR INJECTION
8.2.2.2.2.2.1 PREFILLED INJECTIONS
8.2.2.2.2.2.2 VIAL
8.2.2.2.2.3 EYE DROPS
8.2.2.2.2.4 ORAL PHARMACEUTICAL PREPARATIONS
8.2.2.2.2.5 OTHERS
8.3 HYDROLYZED HYALURONIC ACID
8.3.1 MOLECULAR WEIGHT
8.3.1.1 HIGH MOLECULAR WEIGHT
8.3.1.2 LOW MOLECULAR WEIGHT
8.3.1.3 MEDIUM MOLECULAR WEIGHT
8.3.2 BY TYPE
8.3.2.1 COSMETIC GRADE
8.3.2.1.1 GENDER
8.3.2.1.1.1 FEMALE PRODUCTS
8.3.2.1.1.2 MEN'S PRODUCT
8.3.2.1.2 PRODUCT TYPE
8.3.2.1.2.1 SKIN CARE
8.3.2.1.2.2 MAKEUP
8.3.2.1.2.3 CLEANSING
8.3.2.1.2.4 HAIR CARE
8.3.2.1.2.5 OTHERS
8.3.2.2 PHARMACEUTICAL GRADE
8.3.2.2.1 TYPE
8.3.2.2.1.1 MEDICAL GRADE HYALURONIC ACID
8.3.2.2.1.2 INJECTION GRADE HYALURONIC ACID
8.3.2.2.2 PRODUCT TYPE
8.3.2.2.2.1 TOPICAL PREPARATIONS
8.3.2.2.2.2 INTRA-ARTICULAR INJECTION
8.3.2.2.2.2.1 PREFILLED INJECTIONS
8.3.2.2.2.2.2 VIAL
8.3.2.2.2.3 EYE DROPS
8.3.2.2.2.4 ORAL PHARMACEUTICAL PREPARATIONS
8.3.2.2.2.5 OTHERS
8.4 SODIUM ACETYLATED HYALURONIC ACID
8.4.1 MOLECULAR WEIGHT
8.4.1.1 HIGH MOLECULAR WEIGHT
8.4.1.2 LOW MOLECULAR WEIGHT
8.4.1.3 MEDIUM MOLECULAR WEIGHT
8.4.2 BY TYPE
8.4.2.1 COSMETIC GRADE
8.4.2.1.1 GENDER
8.4.2.1.1.1 FEMALE PRODUCTS
8.4.2.1.1.2 MEN'S PRODUCT
8.4.2.1.2 PRODUCT TYPE
8.4.2.1.2.1 SKIN CARE
8.4.2.1.2.2 MAKEUP
8.4.2.1.2.3 CLEANSING
8.4.2.1.2.4 HAIR CARE
8.4.2.1.2.5 OTHERS
8.4.2.2 PHARMACEUTICAL GRADE
8.4.2.2.1 TYPE
8.4.2.2.1.1 MEDICAL GRADE HYALURONIC ACID
8.4.2.2.1.2 INJECTION GRADE HYALURONIC ACID
8.4.2.2.2 PRODUCT TYPE
8.4.2.2.2.1 TOPICAL PREPARATIONS
8.4.2.2.2.2 INTRA-ARTICULAR INJECTION
8.4.2.2.2.2.1 PREFILLED INJECTIONS
8.4.2.2.2.2.2 VIAL
8.4.2.2.2.3 EYE DROPS
8.4.2.2.2.4 ORAL PHARMACEUTICAL PREPARATIONS
8.4.2.2.2.5 OTHERS
9 NORTH AMERICA HYALURONIC ACID MARKET, BY APPLICATION
9.1 OVERVIEW
9.2 AESTHETICS
9.3 OSTEOARTHRITIS
9.4 COSMETICS
9.5 OPHTHALMOLOGY
9.6 PHARMACEUTICAL API
9.7 OTHERS
10 NORTH AMERICA HYALURONIC ACID MARKET, BY END USER
10.1 OVERVIEW
10.2 DERMATOLOGY CLINICS
10.3 COSMETIC SURGERY CENTERS
10.4 MEDICAL SPAS AND BEAUTY CENTERS
10.5 OTHERS
11 NORTH AMERICA HYALURONIC ACID MARKET, BY DISTRIBUTION CHANNEL
11.1 OVERVIEW
11.2 RETAIL SALES
11.2.1 RETAIL PHARMACY
11.2.2 HOSPITAL PHARMACY
11.2.3 ONLINE PHARMACY
11.3 DIRECT TENDER
12 NORTH AMERICA HYALURONIC ACID MARKET, BY REGION
12.1 NORTH AMERICA
12.1.1 U.S.
12.1.2 CANADA
12.1.3 MEXICO
13 NORTH AMERICA HYALURONIC ACID MARKET: COMPANY LANDSCAPE
13.1 COMPANY SHARE ANALYSIS: NORTH AMERICA
14 SWOT ANALYSIS
15 COMPANY PROFILE
15.1 FIDIA FARMACEUTICI S.P.A. (2022)
15.1.1 COMPANY SNAPSHOT
15.1.2 REVENUE ANALYSIS
15.1.3 COMPANY SHARE ANALYSIS
15.1.4 PRODUCT PORTFOLIO
15.1.5 RECENT DEVELOPMENT
15.2 ABBVIE INC.
15.2.1 COMPANY SNAPSHOT
15.2.2 REVENUE ANALYSIS
15.2.3 COMPANY SHARE ANALYSIS
15.2.4 PRODUCT PORTFOLIO
15.2.5 RECENT DEVELOPMENTS
15.3 BLOOMAGE BIOTECHNOLOGY CORPORATION LIMITED
15.3.1 COMPANY SNAPSHOT
15.3.2 COMPANY SHARE ANALYSIS
15.3.3 PRODUCT PORTFOLIO
15.3.4 RECENT DEVELOPMENTS
15.4 GALDERMA
15.4.1 COMPANY SNAPSHOT
15.4.2 COMPANY SHARE ANALYSIS
15.4.3 PRODUCT PORTFOLIO
15.4.4 RECENT DEVELOPMENTS
15.5 LG CHEM (2022)
15.5.1 COMPANY SNAPSHOT
15.5.2 REVENUE ANALYSIS
15.5.3 COMPANY SHARE ANALYSIS
15.5.4 PRODUCT PORTFOLIO
15.5.5 RECENT DEVELOPMENTS
15.6 ABBOTT (2022)
15.6.1 COMPANY SNAPSHOT
15.6.2 REVENUE ANALYSIS
15.6.3 PRODUCT PORTFOLIO
15.6.4 RECENT DEVELOPMENTS
15.7 ANIKA THERAPEUTICS, INC.
15.7.1 COMPANY SNAPSHOT
15.7.2 REVENUE ANALYSIS
15.7.3 COMPANY SHARE ANALYSIS
15.7.4 PRODUCT PORTFOLIO
15.7.5 RECENT DEVELOPMENTS
15.8 BIOSCIENCE GMBH
15.8.1 COMPANY SNAPSHOT
15.8.2 PRODUCT PORTFOLIO
15.8.3 RECENT DEVELOPMENT
15.9 BIOXIS PHARMACEUTICALS
15.9.1 COMPANY SNAPSHOT
15.9.2 PRODUCT PORTFOLIO
15.9.3 RECENT DEVELOPMENTS
15.1 BIOIBERICA S.A.U
15.10.1 COMPANY SNAPSHOT
15.10.2 PRODUCT PORTFOLIO
15.10.3 RECENT DEVELOPMENTS
15.11 BOHUS BIOTECH AB
15.11.1 COMPANY SNAPSHOT
15.11.2 PRODUCT PORTFOLIO
15.11.3 RECENT DEVELOPMENTS
15.12 BRICKELL MEN'S PRODUCTS
15.12.1 COMPANY SNAPSHOT
15.12.2 PRODUCT PORTFOLIO
15.12.3 RECENT DEVELOPMENT
15.13 CONTIPRO A.S.
15.13.1 COMPANY SNAPSHOT
15.13.2 PRODUCT PORTFOLIO
15.13.3 RECENT DEVELOPMENTS
15.14 FILLMED
15.14.1 COMPANY SNAPSHOT
15.14.2 PRODUCT PORTFOLIO
15.14.3 RECENT DEVELOPMENT
15.15 GENESIS
15.15.1 COMPANY SNAPSHOT
15.15.2 PRODUCT PORTFOLIO
15.15.3 RECENT DEVELOPMENT
15.16 HUONS
15.16.1 COMPANY SNAPSHOT
15.16.2 PRODUCT PORTFOLIO
15.16.3 RECENT DEVELOPMENTS
15.17 KEWPIE CORPORATION
15.17.1 COMPANY SNAPSHOT
15.17.2 PRODUCT PORTFOLIO
15.17.3 RECENT DEVELOPMENTS
15.18 LIFECORE BIOMEDICAL, INC.(2022)
15.18.1 COMPANY SNAPSHOT
15.18.2 REVENUE ANALYSIS
15.18.3 PRODUCT PORTFOLIO
15.18.4 RECENT DEVELOPMENTS
15.19 MERZ NORTH AMERICA, INC. (A SUBSIDIARY OF MERZ PHARMA)
15.19.1 COMPANY SNAPSHOT
15.19.2 PRODUCT PORTFOLIO
15.19.3 RECENT DEVELOPMENTS
15.2 PROLLENIUM MEDICAL TECHNOLOGIES
15.20.1 COMPANY SNAPSHOT
15.20.2 PRODUCT PORTFOLIO
15.20.3 RECENT DEVELOPMENTS
15.21 RIVER PHARMA S.R.L.
15.21.1 COMPANY SNAPSHOT
15.21.2 PRODUCT PORTFOLIO
15.21.3 RECENT DEVELOPMENT
15.22 SHANDONG TOPSCIENCE BIOTECH CO., LTD.
15.22.1 COMPANY SNAPSHOT
15.22.2 PRODUCT PORTFOLIO
15.22.3 RECENT DEVELOPMENTS
15.23 STANFORD CHEMICALS OWNED BY OCEANIA INTERNATIONAL LLC,
15.23.1 COMPANY SNAPSHOT
15.23.2 PRODUCT PORTFOLIO
15.23.3 RECENT DEVELOPMENTS
15.24 SYMATESE
15.24.1 COMPANY SNAPSHOT
15.24.2 PRODUCT PORTFOLIO
15.24.3 RECENT DEVELOPMENTS
15.25 TEOXANE
15.25.1 COMPANY SNAPSHOT
15.25.2 PRODUCT PORTFOLIO
15.25.3 RECENT DEVELOPMENTS
15.26 VIRCHOW BIOTECH
15.26.1 COMPANY SNAPSHOT
15.26.2 PRODUCT PORTFOLIO
15.26.3 RECENT DEVELOPMENTS
16 QUESTIONNAIRE
17 RELATED REPORTS
表格列表
TABLE 1 U.S. AESTHETIC PLASTIC SURGERY PROCEDURES COUNT IN 2021 AND 2020:
TABLE 2 REQUIRED TIME, NUMBER OF TREATMENTS, REST TIME
TABLE 3 NORTH AMERICA HYALURONIC ACID MARKET, BY GRADE, 2021-2030 (USD MILLION)
TABLE 4 NORTH AMERICA COSMETIC GRADE IN HYALURONIC ACID MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 5 NORTH AMERICA COSMETIC GRADE IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)
TABLE 6 NORTH AMERICA COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 7 NORTH AMERICA COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PROCEDURE, 2021-2030 (USD MILLION)
TABLE 8 NORTH AMERICA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 9 NORTH AMERICA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 10 NORTH AMERICA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 11 NORTH AMERICA INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 12 NORTH AMERICA HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 13 NORTH AMERICA SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 14 NORTH AMERICA SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)
TABLE 15 NORTH AMERICA SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 16 NORTH AMERICA COSMETIC GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)
TABLE 17 NORTH AMERICA COSMETIC GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 18 NORTH AMERICA PHARMACEUTICAL GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 19 NORTH AMERICA PHARMACEUTICAL GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 20 NORTH AMERICA INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 21 NORTH AMERICA HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 22 NORTH AMERICA HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)
TABLE 23 NORTH AMERICA HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 24 NORTH AMERICA COSMETIC GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)
TABLE 25 NORTH AMERICA COSMETIC GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 26 NORTH AMERICA PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 27 NORTH AMERICA PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 28 NORTH AMERICA INTRA-ARTICULAR INJECTION IN PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 29 NORTH AMERICA SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 30 NORTH AMERICA SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)
TABLE 31 NORTH AMERICA SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 32 NORTH AMERICA COSMETIC GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)
TABLE 33 NORTH AMERICA COSMETIC GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 34 NORTH AMERICA PHARMACEUTICAL GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 35 NORTH AMERICA PHARMACEUTICAL GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 36 NORTH AMERICA INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 37 NORTH AMERICA HYALURONIC ACID MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 38 NORTH AMERICA AESTHETICS IN HYALURONIC ACID MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 39 NORTH AMERICA OSTEOARTHRITIS IN HYALURONIC ACID MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 40 NORTH AMERICA COSMETICS IN HYALURONIC ACID MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 41 NORTH AMERICA OPHTHALMOLOGY IN HYALURONIC ACID MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 42 NORTH AMERICA PHARMACEUTICAL API IN HYALURONIC ACID MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 43 NORTH AMERICA OTHERS IN HYALURONIC ACID MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 44 NORTH AMERICA HYALURONIC ACID MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 45 NORTH AMERICA DERMATOLOGY CLINICS IN HYALURONIC ACID MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 46 NORTH AMERICA COSMETIC SURGERY CENTERS IN HYALURONIC ACID MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 47 NORTH AMERICA MEDICAL SPAS AND BEAUTY CENTERS IN HYALURONIC ACID MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 48 NORTH AMERICA OTHERS IN HYALURONIC ACID MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 49 NORTH AMERICA HYALURONIC ACID MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 50 NORTH AMERICA RETAIL SALES IN HYALURONIC ACID MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 51 NORTH AMERICA RETAIL SALES IN HYALURONIC ACID MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 52 NORTH AMERICA DIRECT TENDER IN HYALURONIC ACID MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 53 NORTH AMERICA HYALURONIC ACID MARKET, BY COUNTRY, 2021-2030 (USD MILLION)
TABLE 54 NORTH AMERICA HYALURONIC ACID MARKET, BY GRADE, 2021-2030 (USD MILLION)
TABLE 55 NORTH AMERICA COSMETIC GRADE IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)
TABLE 56 NORTH AMERICA COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 57 NORTH AMERICA COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME IN MILLION UNITS)
TABLE 58 NORTH AMERICA COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)
TABLE 59 NORTH AMERICA COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PROCEDURE, 2021-2030 (USD MILLION)
TABLE 60 NORTH AMERICA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 61 NORTH AMERICA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (VOLUME IN MILLION UNITS)
TABLE 62 NORTH AMERICA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (ASP IN USD)
TABLE 63 NORTH AMERICA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 64 NORTH AMERICA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME IN MILLION UNITS)
TABLE 65 NORTH AMERICA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)
TABLE 66 NORTH AMERICA INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 67 NORTH AMERICA INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME IN MILLION UNITS)
TABLE 68 NORTH AMERICA INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)
TABLE 69 NORTH AMERICA HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 70 NORTH AMERICA SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)
TABLE 71 NORTH AMERICA SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 72 NORTH AMERICA COSMETIC GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)
TABLE 73 NORTH AMERICA COSMETIC GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 74 NORTH AMERICA PHARMACEUTICAL GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 75 NORTH AMERICA PHARMACEUTICAL GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 76 NORTH AMERICA INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 77 NORTH AMERICA HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)
TABLE 78 NORTH AMERICA HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 79 NORTH AMERICA COSMETIC GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)
TABLE 80 NORTH AMERICA COSMETIC GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 81 NORTH AMERICA PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 82 NORTH AMERICA PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 83 NORTH AMERICA INTRA-ARTICULAR INJECTION IN PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 84 NORTH AMERICA SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)
TABLE 85 NORTH AMERICA SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 86 NORTH AMERICA COSMETIC GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)
TABLE 87 NORTH AMERICA COSMETIC GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 88 NORTH AMERICA PHARMACEUTICAL GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 89 NORTH AMERICA PHARMACEUTICAL GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 90 NORTH AMERICA INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 91 NORTH AMERICA HYALURONIC ACID MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 92 NORTH AMERICA HYALURONIC ACID MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 93 NORTH AMERICA HYALURONIC ACID MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 94 NORTH AMERICA RETAIL SALES IN HYALURONIC ACID MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 95 U.S. HYALURONIC ACID MARKET, BY GRADE, 2021-2030 (USD MILLION)
TABLE 96 U.S. COSMETIC GRADE IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)
TABLE 97 U.S. COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 98 U.S. COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME IN MILLION UNITS)
TABLE 99 U.S. COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)
TABLE 100 U.S. COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PROCEDURE, 2021-2030 (USD MILLION)
TABLE 101 U.S. PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 102 U.S. PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (VOLUME IN MILLION UNITS)
TABLE 103 U.S. PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (ASP IN USD)
TABLE 104 U.S. PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 105 U.S. PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME IN MILLION UNITS)
TABLE 106 U.S. PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)
TABLE 107 U.S. INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 108 U.S. INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME IN MILLION UNITS)
TABLE 109 U.S. INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)
TABLE 110 U.S. HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 111 U.S. SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)
TABLE 112 U.S. SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 113 U.S. COSMETIC GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)
TABLE 114 U.S. COSMETIC GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 115 U.S. PHARMACEUTICAL GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 116 U.S. PHARMACEUTICAL GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 117 U.S. INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 118 U.S. HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)
TABLE 119 U.S. HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 120 U.S. COSMETIC GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)
TABLE 121 U.S. COSMETIC GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 122 U.S. PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 123 U.S. PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 124 U.S. INTRA-ARTICULAR INJECTION IN PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 125 U.S. SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)
TABLE 126 U.S. SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 127 U.S. COSMETIC GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)
TABLE 128 U.S. COSMETIC GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 129 U.S. PHARMACEUTICAL GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 130 U.S. PHARMACEUTICAL GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 131 U.S. INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 132 U.S. HYALURONIC ACID MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 133 U.S. HYALURONIC ACID MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 134 U.S. HYALURONIC ACID MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 135 U.S. RETAIL SALES IN HYALURONIC ACID MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 136 CANADA HYALURONIC ACID MARKET, BY GRADE, 2021-2030 (USD MILLION)
TABLE 137 CANADA COSMETIC GRADE IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)
TABLE 138 CANADA COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 139 CANADA COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME IN MILLION UNITS)
TABLE 140 CANADA COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)
TABLE 141 CANADA COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PROCEDURE, 2021-2030 (USD MILLION)
TABLE 142 CANADA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 143 CANADA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (VOLUME IN MILLION UNITS)
TABLE 144 CANADA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (ASP IN USD)
TABLE 145 CANADA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 146 CANADA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME IN MILLION UNITS)
TABLE 147 CANADA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)
TABLE 148 CANADA INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 149 CANADA INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME IN MILLION UNITS)
TABLE 150 CANADA INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)
TABLE 151 CANADA HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 152 CANADA SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)
TABLE 153 CANADA SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 154 CANADA COSMETIC GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)
TABLE 155 CANADA COSMETIC GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 156 CANADA PHARMACEUTICAL GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 157 CANADA PHARMACEUTICAL GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 158 CANADA INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 159 CANADA HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)
TABLE 160 CANADA HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 161 CANADA COSMETIC GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)
TABLE 162 CANADA COSMETIC GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 163 CANADA PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 164 CANADA PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 165 CANADA INTRA-ARTICULAR INJECTION IN PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 166 CANADA SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)
TABLE 167 CANADA SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 168 CANADA COSMETIC GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)
TABLE 169 CANADA COSMETIC GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 170 CANADA PHARMACEUTICAL GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 171 CANADA PHARMACEUTICAL GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 172 CANADA INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 173 CANADA HYALURONIC ACID MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 174 CANADA HYALURONIC ACID MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 175 CANADA HYALURONIC ACID MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 176 CANADA RETAIL SALES IN HYALURONIC ACID MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 177 MEXICO HYALURONIC ACID MARKET, BY GRADE, 2021-2030 (USD MILLION)
TABLE 178 MEXICO COSMETIC GRADE IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)
TABLE 179 MEXICO COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 180 MEXICO COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME IN MILLION UNITS)
TABLE 181 MEXICO COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)
TABLE 182 MEXICO COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PROCEDURE, 2021-2030 (USD MILLION)
TABLE 183 MEXICO PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 184 MEXICO PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (VOLUME IN MILLION UNITS)
TABLE 185 MEXICO PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (ASP IN USD)
TABLE 186 MEXICO PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 187 MEXICO PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME IN MILLION UNITS)
TABLE 188 MEXICO PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)
TABLE 189 MEXICO INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 190 MEXICO INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME IN MILLION UNITS)
TABLE 191 MEXICO INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)
TABLE 192 MEXICO HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 193 MEXICO SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)
TABLE 194 MEXICO SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 195 MEXICO COSMETIC GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)
TABLE 196 MEXICO COSMETIC GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 197 MEXICO PHARMACEUTICAL GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 198 MEXICO PHARMACEUTICAL GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 199 MEXICO INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 200 MEXICO HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)
TABLE 201 MEXICO HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 202 MEXICO COSMETIC GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)
TABLE 203 MEXICO COSMETIC GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 204 MEXICO PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 205 MEXICO PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 206 MEXICO INTRA-ARTICULAR INJECTION IN PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 207 MEXICO SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)
TABLE 208 MEXICO SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 209 MEXICO COSMETIC GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)
TABLE 210 MEXICO COSMETIC GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 211 MEXICO PHARMACEUTICAL GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 212 MEXICO PHARMACEUTICAL GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 213 MEXICO INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 214 MEXICO HYALURONIC ACID MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 215 MEXICO HYALURONIC ACID MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 216 MEXICO HYALURONIC ACID MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 217 MEXICO RETAIL SALES IN HYALURONIC ACID MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
图片列表
FIGURE 1 NORTH AMERICA HYALURONIC ACID MARKET: SEGMENTATION
FIGURE 2 NORTH AMERICA HYALURONIC ACID MARKET: DATA TRIANGULATION
FIGURE 3 NORTH AMERICA HYALURONIC ACID MARKET: DROC ANALYSIS
FIGURE 4 NORTH AMERICA HYALURONIC ACID MARKET: NORTH AMERICA VS REGIONAL MARKET ANALYSIS
FIGURE 5 NORTH AMERICA HYALURONIC ACID MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 NORTH AMERICA HYALURONIC ACID MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 NORTH AMERICA HYALURONIC ACID MARKET: DBMR POSITION GRID
FIGURE 8 NORTH AMERICA HYALURONIC ACID MARKET: VENDOR SHARE ANALYSIS
FIGURE 9 NORTH AMERICA HYALURONIC ACID MARKET: END USER COVERAGE GRID
FIGURE 10 NORTH AMERICA HYALURONIC ACID MARKET: SEGMENTATION
FIGURE 11 RISING POPULARITY OF NON-SURGICAL OR MINIMALLY INVASIVE COSMETIC PROCEDURES IS EXPECTED TO DRIVE THE NORTH AMERICA HYALURONIC ACID MARKET FROM 2023 TO 2030
FIGURE 12 THE GRADE SEGMENT IS EXPECTED TO HAVE THE LARGEST SHARE OF THE NORTH AMERICA HYALURONIC ACID MARKET FROM 2023 TO 2030
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF NORTH AMERICA HYALURONIC ACID MARKET
FIGURE 14 NORTH AMERICA HYALURONIC ACID MARKET: BY GRADE, 2022
FIGURE 15 NORTH AMERICA HYALURONIC ACID MARKET: BY GRADE, 2023-2030 (USD MILLION)
FIGURE 16 NORTH AMERICA HYALURONIC ACID MARKET: BY GRADE, CAGR (2023-2030)
FIGURE 17 NORTH AMERICA HYALURONIC ACID MARKET: BY GRADE, LIFELINE CURVE
FIGURE 18 NORTH AMERICA HYALURONIC ACID MARKET: BY TYPE, 2022
FIGURE 19 NORTH AMERICA HYALURONIC ACID MARKET: BY TYPE, 2023-2030 (USD MILLION)
FIGURE 20 NORTH AMERICA HYALURONIC ACID MARKET: BY TYPE, CAGR (2023-2030)
FIGURE 21 NORTH AMERICA HYALURONIC ACID MARKET: BY TYPE, LIFELINE CURVE
FIGURE 22 NORTH AMERICA HYALURONIC ACID MARKET: BY APPLICATION, 2022
FIGURE 23 NORTH AMERICA HYALURONIC ACID MARKET: BY APPLICATION, 2023-2030 (USD MILLION)
FIGURE 24 NORTH AMERICA HYALURONIC ACID MARKET: BY APPLICATION, CAGR (2023-2030)
FIGURE 25 NORTH AMERICA HYALURONIC ACID MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 26 NORTH AMERICA HYALURONIC ACID MARKET: BY END USER, 2022
FIGURE 27 NORTH AMERICA HYALURONIC ACID MARKET: BY END USER, 2023-2030 (USD MILLION)
FIGURE 28 NORTH AMERICA HYALURONIC ACID MARKET: BY END USER, CAGR (2023-2030)
FIGURE 29 NORTH AMERICA HYALURONIC ACID MARKET: BY END USER, LIFELINE CURVE
FIGURE 30 NORTH AMERICA HYALURONIC ACID MARKET: BY DISTRIBUTION CHANNEL, 2022
FIGURE 31 NORTH AMERICA HYALURONIC ACID MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION)
FIGURE 32 NORTH AMERICA HYALURONIC ACID MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030)
FIGURE 33 NORTH AMERICA HYALURONIC ACID MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 34 NORTH AMERICA HYALURONIC ACID MARKET: SNAPSHOT (2022)
FIGURE 35 NORTH AMERICA HYALURONIC ACID MARKET: BY COUNTRY (2022)
FIGURE 36 NORTH AMERICA HYALURONIC ACID MARKET: BY COUNTRY (2023 & 2030)
FIGURE 37 NORTH AMERICA HYALURONIC ACID MARKET: BY COUNTRY (2022 & 2030)
FIGURE 38 NORTH AMERICA HYALURONIC ACID MARKET: GRADE (2023-2030)
FIGURE 39 NORTH AMERICA HYALURONIC ACID MARKET: COMPANY SHARE 2022 (%)
研究方法
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
可定制
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
